Viravaxx AG
Records under this name other than the patents Viravaxx AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 2 of 2 · Back to Viravaxx AG
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,237,166 | Method for detecting HIV-1-specific antibodies using clade C env polypeptides Lapsed on the fee record Ended Feb 1, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 1, 2026 | From the USPTO record |
| US 9,638,694 | Method for diagnosing a rhinovirus infection Lapsed on the fee record Ended May 2, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 2, 2025 | From the USPTO record |